# Early Immune Responses to Inactivated Influenza Vaccine: a Pilot Study

> **NCT01522248** · NA · COMPLETED · sponsor: **Johns Hopkins Bloomberg School of Public Health** · enrollment: 20 (actual)

## Conditions studied

- Influenza Virus Vaccine

## Interventions

- **BIOLOGICAL:** Trivalent Inactivated Influenza vaccine

## Key facts

- **NCT ID:** NCT01522248
- **Lead sponsor:** Johns Hopkins Bloomberg School of Public Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01522248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01522248, "Early Immune Responses to Inactivated Influenza Vaccine: a Pilot Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01522248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*